Advertisement
Pharmacy Today, December 2012
December 01, 2012
December 2012 • Volume 18, Number 12
Features
39 Omacetaxine: Accelerated approval granted to novel agent for refractory CML
42 Perampanel: New drug indicated for adjunctive therapy for partial-onset seizures
44 Ocriplasmin: First-ever agent for symptomatic vitreomacular adhesion
46 MTM profile: Giberson promotes expanded pharmacy practice, provider status
49 Fungal meningitis: FDA reports on inspections of NECC, Ameridose facilities
50 Compounding: Post for your patients; Frequently asked questions about pharmaceutical compounding
54 Project IMPACT: Public health in Alabama helps patients, educates students
Policy and Advocacy
58 On the docket: Pharmacist–expert's report ruled sufficient
59 Hub on policy and advocacy: ACA implementation; Congress to tackle compounding
62 DEA scrutiny: Drug distributors, wholesalers under the magnifying glass
64 Electronic health records: Pharmacists can contribute to meaningful use
Departments
4 Letter to the editor: Value of APhA membership
6 Today's perspective: Holiday wish: Better med use
12 Pharmacists in action: CEO editorial, 'Minute with' Susan Holden, JFPS 2012
23 Product showcase: New indications, formulations, generics; product withdrawal
24 OTCs today: OTC antihistamines in older patients
27 Integrative medicine: Zinc supplements in ADHD
28 Immunization update: Tdap in pregnancy; HPV vaccine
31 One to one: Counseling special populations
33 MTM pearls: Facilitating change in pharmacy practice
80 ISMP error alert: Incorporating health literacy concerns into design of medication labels
Health-System Edition
HSE 2 Insomnia: Meeting 2013 National Patient Safety Goals
HSE 4 Many faces of MTM: Poppe ensures tech competency to move practice forward at UNC Hospitals
HSE 8 Antimicrobial stewardship: AHRQ toolkit targets C. difficile infections
Related Content
